Acasti Pharma (ACST.V) announced today that it has initiated its planned pharmacokinetic (PK) bridging study to evaluate the bioavailability of intravenous (IV) GTX-104 compared to oral nimodipine capsules in…
Robertson
Week in Review (Week 6) I’ll admit, over the last couple of weeks I have consumed more meat-based dishes than I have plant-based. Does this make me an omnivore,…
Numinus Wellness (NUMI.V) announced today that it has closed its acquisition of the Neurology Centre of Toronto (NCT). “NCT by Numinus represents an important paradigm shift in neurologic care…By…
Aurora Cannabis (ACB.T) announced on Tuesday that it will be shutting down its Aurora Polaris facility in Edmonton, Alberta. Furthermore, the Company has stated that approximately 12% of its…
Sixth Wave (SIXW.C) announced today that it has received additional grant funding for its joint research project with York University. “The grant provides the Company a significant opportunity to…
Izotropic Corporation (IZO.C) announced today that it has entered into an agreement with Johns Hopkins University School of Medicine (JHU) to develop image reconstruction software to further improve the…
Draganfly Inc. (DPRO.C) announced today that its Vital Intelligence Smart Vital system has been integrated into Fobi AI Inc.’s (FOBI.V) Venue Management System for Conferences & Events. “Draganfly’s Vital…
PlantX Life (VEGA.C) announced today that it has launched as a Seller on Walmart Marketplace in the United States. “Having access to Walmart’s entire marketplace ecosystem throughout Canada and the…
Edesa Biotech (EDSA.Q) announced positive results today from its Phase 2 portion of an ongoing Phase 2/3 clinical study. This study is intended to evaluate EB05, the Company’s monoclonal…
Protagonist Therapeutics (PTGX.Q) announced the receipt of verbal communication from the U.S. Food and Drug Administration (FDA) that the Company’s clinical studies for rusfertide have been placed on a…